article Open AccessTop 10% cited

Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma

Clinical Cancer Research · 2014 · Vol. 20(23) · pp. 6212–6222

Bo Hu(Ministry of Education)Xin‐Rong Yang(Ministry of Education)Yang Xu(Ministry of Education)Yun‐Fan Sun(Ministry of Education)Chao Sun(Ministry of Education)Wei Guo(Fudan University)Xin Zhang(Ministry of Education)Weimin Wang(Ministry of Education)Shuang–Jian Qiu(Ministry of Education)Jian Zhou(Fudan University)Jia Fan✉(Fudan University)

View via DOI Full-text PDF

Abstract

The SII was a powerful prognostic indicator of poor outcome in patients with HCC and is a promising tool for HCC treatment strategy decisions. The dismal outcome in patients with high SII scores might be related to higher CTC levels.

Inflammatory Biomarkers in Disease Prognosis Cancer Immunotherapy and Biomarkers Cancer, Lipids, and MetabolismHepatocellular carcinomaMedicineInflammationResectionImmune systemInternal medicineSystemic inflammationOncologyCarcinomaGastroenterology

MeSH terms

AdultAgedFemaleCarcinoma, HepatocellularHumansInflammationLiver NeoplasmsMaleMiddle AgedNeoplasm Recurrence, LocalPrognosisRetrospective StudiesRisk FactorsCohort StudiesTumor Burden

Citations

2,212

FWCI

8.95

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Systemic immune-inflammation index for predicting prognosis of colorectal cancer